Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
An observational study completed in Japan evaluating the safety of rivaroxaban for treating venous thromboembolism in children.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
Clinical trial evaluating thromboembolic and hemorrhagic complications of anticoagulant treatment in patients with cancer-associated thrombo…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
A retrospective study examining venous thromboembolism in patients with hematologic cancers and post-hematopoietic cell transplant, focusing…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Venous Thromboembolism (VTE) Knowledge
A completed clinical trial update evaluating knowledge about venous thromboembolism (VTE) conducted by The Chinese University of Hong Kong.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
This clinical trial update covers a study on thrombography in pregnant women and the in vitro effects of low molecular weight heparin, and t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Pfizer-sponsored trial assessing treatment patterns for venous thromboembolism in United States patients has completed, with results posted.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Risk Factors for Thrombosis in Children With Central Venous Lines
This completed clinical trial investigates risk factors for thrombosis in children with central venous lines.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Thromboembolic Complications in Mild Covid-19 Cases
A completed clinical trial from Marmara University Pendik Training and Research Hospital assessing thromboembolic complications in patients …
-
CLINICAL_TRIALS withdrawal · 2024-11-13Clinical Trial Update: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm
The trial evaluating the XAPPORT decision-support app for managing anticoagulation in patients treated with rivaroxaban undergoing elective …
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Cancer-related Venous Thromboembolic Disease - Cohort Study
An update on a cohort study examining cancer-related venous thromboembolism is described; the study has not yet started recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis
A completed clinical trial compares safety and effectiveness of warfarin versus apixaban in patients with end-stage kidney disease on dialys…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT) [NA]
This clinical trial is evaluating whether the residual pulmonary vascular obstruction index computed from ventilation/perfusion SPECT/CT can…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort
Observational US cohort study evaluating rivaroxaban for treatment and prophylaxis of venous thromboembolism in cancer patients; study compl…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
A terminated trial sponsored by Sanofi comparing extended versus conventional duration of enoxaparin prophylaxis for preventing venous throm…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Apixaban for the Acute Treatment of Venous Thromboembolism in Children [Phase 4]
Phase 4 clinical trial results assess the safety and efficacy of apixaban for acute treatment of venous thromboembolism in children; the stu…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin
This terminated clinical trial compared higher-dose or extended-duration enoxaparin versus conventional dosing for venous thromboembolism pr…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial [Phase 2, Phase 3]
A multicenter pilot randomized trial is evaluating anti-Xa guided dosing of low molecular weight heparin to prevent venous thromboembolism a…
-
FDA approval · 2024-10-24FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indication…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis
A recruiting clinical trial is evaluating the incidence of anti-platelet factor 4 antibodies in adults aged 18 to 60 with spontaneous, infec…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Efficacy of Aspirin in Preventing Venous Thromboembolism [Phase 4]
Phase 4 study evaluating whether aspirin reduces venous thromboembolism after total joint arthroplasty; the study has completed.
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation [Phase 3]
Phase 3 clinical trial evaluating apixaban for stroke prophylaxis in patients with atrial fibrillation and advanced chronic kidney disease (…
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE [Phase 4]
Phase 4 clinical trial update comparing peripheral systemic thrombolysis versus catheter-directed thrombolysis for submassive pulmonary embo…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: The Affect Of An Anti-Embolism Stocking Protocol [NA]
Completed clinical trial evaluating the effect of an anti-embolism stocking protocol on venous thromboembolism.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Achilles Tendon Rupture - Intervention With Electrical Stimulation [NA]
This entry notes a clinical trial at Karolinska University Hospital evaluating electrical stimulation to aid recovery after Achilles tendon …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
The Gynecological Cancer Associated Thrombosis (GynCAT) study is currently recruiting to investigate cancer-associated thrombosis and venous…